reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Kiromic Biopharma, Inc.

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$3Mstalepublic float
2023-03-31most recent failure
2025-03-21filed for bankruptcy

Score over time

0123202220232024202520262022-01-01 · score 12021-11-16 filed late (10-Q) · accounts not ready2022-04-01 · score 12021-11-16 filed late (10-Q) · accounts not ready2022-07-01 · score 32022-05-03 auditor change2022-04-01 filed late (10-K) · accounts not ready2021-11-16 filed late (10-Q) · accounts not ready2022-10-01 · score 32022-05-03 auditor change2022-04-01 filed late (10-K) · accounts not ready2021-11-16 filed late (10-Q) · accounts not ready2023-01-01 · score 22022-05-03 auditor change2022-04-01 filed late (10-K) · accounts not ready2023-04-01 · score 32023-03-31 filed late (10-K) · accounts not ready2022-05-03 auditor change2022-04-01 filed late (10-K) · accounts not ready2023-07-01 · score 12023-03-31 filed late (10-K) · accounts not ready2023-10-01 · score 12023-03-31 filed late (10-K) · accounts not ready2024-01-01 · score 12023-03-31 filed late (10-K) · accounts not ready

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Kiromic BioPharma, Inc. (the “Company”) is working diligently to complete its annual report on Form 10-K for the fiscal year ended December 31, 2022 (the “2022 Form 10-K”); however, the Company continues to be in the process of completing its review and approval of the Form 10-K, including the financial statements and related disclosures, therefore the Company is unable to complete and file the 2022 Form 10-K by the required due date of March 31, 2023 without unreasonable effort and expense. The Company expects to file the 2022 Form 10-K no later than 15 calendar days after its originally prescribed due date

NT 10-K, filed 2023-03-31 · accounts not ready

What it filed

2023-03-31filed late (10-K)accounts not ready SEC →

Kiromic BioPharma, Inc. (the “Company”) is working diligently to complete its annual report on Form 10-K for the fiscal year ended December 31, 2022 (the “2022 Form 10-K”); however, the Company continues to be in the process of completing its review and approval of the Form 10-K, including the financial statements and related disclosures, therefore the Company is unable to complete and file the 2022 Form 10-K by the required due date of March 31, 2023 without unreasonable effort and expense. The Company expects to file the 2022 Form 10-K no later than 15 calendar days after its originally prescribed due date

2022-05-03auditor changed or resigned SEC →

2022-04-01filed late (10-K)accounts not ready SEC →

Kiromic BioPharma, Inc. (t he “Company”) is working diligently to complete its annual report on Form 10-K for the fiscal year ended December 31, 2021 (the “2021 Form 10-K”); however, the Company continues to be in the process of completing its review and approval of the Form 10-K, including the financial statements and related disclosures, therefore the Company is unable to complete and file the 2021 Form 10-K by the required due date of March 31, 2022 without unreasonable effort and expense. The Company expects to file the 2021 Form 10-K no later than 15 calendar days after its originally prescribed due date

2021-11-16filed late (10-Q)accounts not ready SEC →

The Company is working diligently to complete the Q3 2021 Form 10-Q; however, due to ongoing review of additional disclosure the Company is unable to complete and file the Q3 2021 Form 10-Q by the required due date of November 15, 2021 without unreasonable effort and expense

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com